The BK channel-NS1619 agonist complex reveals molecular insights into allosteric activation gating
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2507707123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Naileth Gonzalez-Sanabria und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637. Hauptthemen laut MEDLINE: Benzimidazoles, Ion Channel Gating, Large-Conductance Calcium-Activated Potassium Channels. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation for the National Institutes of Health (FNIH), ANID | Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT), Agencia Nacional de Investigación y Desarrollo (ANID).
Abstract (Originalsprache)
BK channels play essential roles in a wealth of physiological functions, including regulating smooth muscle tone and neurotransmitter release. Its dysfunction, often caused by loss-of-function mutations, can lead to severe phenotypes, including ataxia and sensory impairment. Despite the therapeutic potential of BK channel agonists, the molecular mechanisms by which they stabilize the pore’s open conformation remain unclear. Using cryoelectron microscopy and molecular dynamic simulations, we identified that NS1619, a synthetic benzimidazolone agonist, first described as a BK opener, binds within a pocket formed by the S6/RCK1 linker and the S4 transmembrane segment. Our simulations suggest that agonist binding promotes a twisting motion in the S6 segment, enabling critical interactions with residues K330, K331, and F223. These findings provide a molecular model for the mechanism of NS1619 and suggest that its binding site can accommodate other agonists, highlighting a promising target for therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637.
- Centro Interdisciplinario de Neurociencia de Valparaiso, Instituto de Neurociencia, Facultad de Ciencias, Universidad de Valparaíso Pasaje, Valparaíso 2340000, Chile.
- Center for Bioinformatics and Integrative Biology, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8370146, Chile.
ORCID-Profile: Naileth Gonzalez-Sanabria, Maximiliano Rojas, Yorley Duarte, Fernando D Gonzalez-Nilo, Eduardo Perozo, Ramon Latorre
Förderung
- Foundation for the National Institutes of Health (FNIH)
- ANID | Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT)
- Agencia Nacional de Investigación y Desarrollo (ANID)
- NIGMS NIH HHS
Zitieren
APA
Gonzalez-Sanabria, N., Contreras, G. F., Rojas, M., Duarte, Y., Gonzalez-Nilo, F. D., Perozo, E., & Latorre, R. (2026). The BK channel-NS1619 agonist complex reveals molecular insights into allosteric activation gating. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2507707123
Vancouver
Gonzalez-Sanabria N, Contreras GF, Rojas M, Duarte Y, Gonzalez-Nilo FD, Perozo E, et al. The BK channel-NS1619 agonist complex reveals molecular insights into allosteric activation gating. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2507707123
BibTeX
@article{GonzalezSanabria2026,
author = {Gonzalez-Sanabria, Naileth and Contreras, Gustavo F and Rojas, Maximiliano and Duarte, Yorley and Gonzalez-Nilo, Fernando D and Perozo, Eduardo and Latorre, Ramon},
title = {The BK channel-NS1619 agonist complex reveals molecular insights into allosteric activation gating},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2507707123}
}
EUVIMED